Skip to main content
. 2024 May 5;12(5):500. doi: 10.3390/vaccines12050500

Table A1.

PECO worksheet [68,69].

Item Definition
Population of interest Adults aged 60 years or older having received at least one dose of any respiratory syncytial virus vaccine
Exposure Exposed to RSV infection during the subsequent RSV season
Control/comparator Adults aged 60 years or older not vaccinated against respiratory syncytial virus (placebo)
Outcome Occurrence of lower respiratory tract disease and/or acute respiratory infection